Sensitivities of ciprofloxacin-resistant Mycobacterium tuberculosis clinical isolates to fluoroquinolones: role of mutant DNA gyrase subunits in drug resistance
Authors:
- 1 May 2012
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 39 (5) , 435-439
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Beijing Genotype of Mycobacterium tuberculosis Is Significantly Associated with High-Level Fluoroquinolone Resistance in VietnamAntimicrobial Agents and Chemotherapy, 2009
- Fluoroquinolone Resistance in Mycobacterium tuberculosis and Mutations in gyrA and gyrBAntimicrobial Agents and Chemotherapy, 2009
- Mycobacterium tuberculosis DNA Gyrase as a Target for Drug DiscoveryInfectious Disorders - Drug Targets, 2007
- Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposureJournal of Antimicrobial Chemotherapy, 2007
- Fluoroquinolones for the Treatment of Pulmonary TuberculosisDrugs, 2007
- Evaluation of a New Line Probe Assay for Rapid Identification of gyrA Mutations in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2005
- Multiplex PCR Amplimer Conformation Analysis for Rapid Detection of gyrA Mutations in Fluoroquinolone-Resistant Mycobacterium tuberculosis Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2004
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998
- Mutations in rpo B Gene of Rifampicin Resistant Clinical Isolates of Mycobacterium tuberculosis in JapanKansenshogaku Zasshi, 1995
- Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteersAntimicrobial Agents and Chemotherapy, 1995